Molecular Testing


# Name Of Technique Test Performed
1 PCR Test HLA B27, Thalassemia
2 RT-PCR Tests HPV, HBV, HCV, UTI PANEL, STD PANEL, BCR-ABL1, PML-RARA, ALL, EGFR, JAK2, KRAS, NRAS etc.
3 Genomics WGS, WES, CES, NIPS, HLA Typing, CMA-315K, CMA-750K, CMA-31K+MCC, CMA-750K+MCC etc.
4 Sanger Sequencing QF-PCR, Variant confirmation, MLPA etc.
5 Cytogenetic Single Karyotyping, Couple Karyotyping, FISH etc.
6 Ontogenetic Hereditary Cancer Panel, Pan-Myeloid Panel, Solid Tumor Panel, BRCA Plus Panel, Endometrial Cancer Panel, Complete IHC etc.
7 Markers First Trimester Screening, Second Trimester Screening -Duo

"EMPOWERING WOMEN'S HEALTH THROUGH MOLECULAR PRECISION."

Urinary Tract Infection (UTI) Testing:PCR (Polymerase Chain Reaction) and RT-PCR (Reverse Transcription PCR) are efficient techniques for detecting bacteria like Escherichia coli or other pathogens causing UTIs. These methods offer high sensitivity and specificity, enabling early and accurate diagnosis.

  • Sexually Transmitted Infections (STIs) Testing: PCR and RT-PCR play a crucial role in identifying STIs such as Chlamydia trachoma is, Neustria gonorrhoeae, etc. These techniques enable rapid detection, facilitating timely treatment and prevention of further transmission.
  • Cervicitis Testing: PCR-based techniques are invaluable for diagnosing the causative agents of cervicitis, including Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, herpes simplex virus, or Mycoplasma genitalium. NGS (Next-Generation Sequencing) can provide comprehensive analysis, especially in cases where multiple pathogens are suspected.
  • Cervical Cancer Screening: HPV (Human Papillomavirus) detection and genotyping, performed using PCR and NGS, allow for early identification of high-risk HPV strains associated with cervical cancer. This enables targeted interventions such as vaccination or closer monitoring for high-risk individuals..
  • Breast Cancer Screening: Testing for mutations in BRCA1 and BRCA2 genes commonly performed through techniques like PCR and Sanger sequencing, helps assess a woman's risk of developing breast cancer. Early identification of these mutations allows for personalized screening and preventive measures.
  • Ovarian Cancer Screening: Screening for mutations in genes like BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, and PALB2, using techniques such as NGS and Sanger sequencing, aids in identifying individuals at higher risk of ovarian cancer. This enables proactive management strategies like risk-reducing surgeries or enhanced surveillance.